0001179110-13-013742.txt : 20130903 0001179110-13-013742.hdr.sgml : 20130902 20130903172416 ACCESSION NUMBER: 0001179110-13-013742 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130829 FILED AS OF DATE: 20130903 DATE AS OF CHANGE: 20130903 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: USANA HEALTH SCIENCES INC CENTRAL INDEX KEY: 0000896264 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 870500306 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 BUSINESS PHONE: 8019547100 MAIL ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. STREET 2: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 FORMER COMPANY: FORMER CONFORMED NAME: USANA INC DATE OF NAME CHANGE: 19930125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WENTZ DAVE CENTRAL INDEX KEY: 0001203343 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35024 FILM NUMBER: 131075791 MAIL ADDRESS: STREET 1: 308 W 300 STREET 2: S #203 CITY: SALT LAKE CITY STATE: UT ZIP: 84101 4 1 edgar.xml FORM 4 - X0306 4 2013-08-29 0 0000896264 USANA HEALTH SCIENCES INC USNA 0001203343 WENTZ DAVE 3838 WEST PARKWAY BLVD SALT LAKE CITY UT 84120 0 1 0 0 C.E.O. Common Stock 2013-08-29 4 M 0 31759 26.06 A 505714 D Common Stock 2013-08-29 4 S 0 31759 78.1018 D 473955 D Common Stock 2013-08-30 4 M 0 215 26.06 A 474170 D Common Stock 2013-08-30 4 S 0 215 78.15 D 473955 D Common Stock 2013-09-03 4 M 0 200 26.06 A 474155 D Common Stock 2013-09-03 4 S 0 200 78.00 D 473955 D Stock-Settled Stock Appreciation Rights 26.06 2013-08-29 4 M 0 47694 0 D 2009-07-21 2014-01-21 Common Stock 47694 32306 D Stock-Settled Stock Appreciation Rights 26.06 2013-08-30 4 M 0 323 0 D 2009-07-21 2014-01-21 Common Stock 323 31983 D Stock-Settled Stock Appreciation Rights 26.06 2013-09-03 4 M 0 301 0 D 2009-07-21 2014-01-21 Common Stock 301 31682 D The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights desclosed in Table II. Average Price. Price range was $78.00 to $78.82. James Bramble, as attorney in fact 2013-09-03